Bisoprolol Fumarate NDC 51407-645

NDC codes

FDA NDC Directory

Product NDC (as listed)51407-645Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51407-0645Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51407-645-01	51407064501	100 TABLET in 1 BOTTLE (51407-645-01)Marketed from Mar 23, 2022
51407-645-30	51407064530	30 TABLET in 1 BOTTLE (51407-645-30)Marketed from Mar 23, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bisoprolol Fumarate
Generic name (nonproprietary): bisoprolol fumarate
Active ingredients: Bisoprolol fumarate — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Golden State Medical Supply, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215563
Marketing start: Oct 29, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 51407-645_4ffb30c3-c812-9e7e-e063-6294a90a24b2SPL ID 4ffb30c3-c812-9e7e-e063-6294a90a24b2SPL set ID df37d337-9978-0c31-e053-2a95a90a3258RxCUI 854901, 854905UNII UR59KN573L
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407064501 followed by a unit qualifier and the quantity

Package 51407-0645-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 21, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE BISOPROLOL FUMARATE TABLETS, USP are indicated in the management of hypertension. It may be used alone or in combination with other antihypertensive agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215563

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215563
Product	Strength	Form · route	Labeler	Product NDC
Bisoprolol Fumarate	Bisoprolol fumarate 10 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-646
Bisoprolol Fumarate	Bisoprolol fumarate 5 mg/1	TabletOral	Bryant Ranch Prepack	71335-2178
Bisoprolol Fumarate	Bisoprolol fumarate 10 mg/1	TabletOral	Novitium Pharma LLC	70954-456
Bisoprolol Fumarate	Bisoprolol fumarate 5 mg/1	TabletOral	Novitium Pharma LLC	70954-455